SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000913414-05-000559
Filing Date
2005-02-14
Accepted
2005-02-14 15:18:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 transkaryotictherapies123104.txt SC 13G 64953
  Complete submission text file 0000913414-05-000559.txt   67107
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-47221 | Film No.: 05608995
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 45 FREMONT ST SAN FRANCISCO CA 94105
Business Address 45 FREMONT ST 17TH FL SAN FRANCISCO CA 94105 4155972639
BARCLAYS GLOBAL INVESTORS NA /CA/ (Filed by) CIK: 0000913414 (see all company filings)

IRS No.: 943112180 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000